Primary Sjögren's syndrome and high type I interferon signalling in a kindred with C2 deficiency

Rheumatol Adv Pract. 2022 Mar 21;6(1):rkac018. doi: 10.1093/rap/rkac018. eCollection 2022.

Mathijs Willemsen^{1

2}, Erika Van Nieuwenhove^{1

2

3}, Nasim Sadat Seyed Tabib⁴, Frederik Staels^{1

2

5}, Rik Schrijvers⁵, Lien De Somer^{3

6}, Adrian Liston^{1

2

7}, Stephanie Humblet-Baron^{1

2}, Carine Wouters^{3

6}

¹ Laboratory of Adaptive Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven.
² VIB-KU Leuven Center for Brain and Disease Research.
³ Division Pediatric Rheumatology, Department of Pediatrics, University Hospitals Leuven.
⁴ Department of Chronic Diseases, Metabolism and Ageing, TARGID, KU Leuven.
⁵ Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation.
⁶ Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
⁷ Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK.

No abstract available